ClinConnect ClinConnect Logo
Search / Trial NCT06893692

Otago Exercise Program on Balance, Endurance and Motor Coordination in Pre-school Children

Launched by RIPHAH INTERNATIONAL UNIVERSITY · Mar 19, 2025

Trial Information

Current as of July 09, 2025

Recruiting

Keywords

Otago Exercise Program, Pre School Children Balance Endurance Motor Coordination Physical Development

ClinConnect Summary

This clinical trial is studying the Otago Exercise Program, which focuses on improving balance, endurance, and motor coordination in preschool children aged 3 to 6 years old. The goal is to help young children develop essential movement skills that will support their physical health and encourage them to stay active throughout their lives. The trial will involve two groups: one group will participate in a special exercise program that includes a variety of fun and engaging activities, while the other group will focus on basic balance exercises.

To be eligible for the study, children must be between 3 and 6 years old, able to engage in the exercises, and have a guardian's consent. However, children with certain health conditions, such as orthopedic issues or developmental delays, will not be included. Participants can expect to attend three exercise sessions each week for 12 weeks, with each session lasting about 40-45 minutes. The outcomes of the trial will be measured using simple tests that assess balance and coordination. This research aims to establish a solid foundation for healthy physical activity habits in young children, helping to prevent obesity and promote overall well-being.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Both Genders.
  • 3-6 years age
  • Guardian's informed consent and, children were able to collaborate and engage throughout the intervention.
  • Flamingo test score between 15-30 seconds.
  • Exclusion Criteria:
  • Associated orthopedics conditions.
  • Underlying genetic disorders
  • Developmental Delay

About Riphah International University

Riphah International University is a leading educational institution based in Pakistan, dedicated to advancing healthcare and medical research through innovative clinical trials. With a commitment to excellence in research and education, Riphah emphasizes ethical standards and scientific integrity in its clinical studies. The university collaborates with various stakeholders, including healthcare professionals and industry partners, to enhance patient outcomes and contribute to the global body of medical knowledge. Through its robust research programs, Riphah International University aims to foster a culture of inquiry and improve healthcare delivery both locally and internationally.

Locations

Lahore, Punjab, Pakistan

Patients applied

0 patients applied

Trial Officials

Tooba Kaukab, MS-PPT

Principal Investigator

Riphah International University

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported